Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients

Arabul M., GÜLLÜLÜ M., Yilmaz Y., Eren M. A., Baran B., Gul C. B., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.15, sa.11, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 11
  • Basım Tarihi: 2009
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Anemia is a common finding in dialysis patients. Recent evidence has accrued that hepcidin, an iron regulatory peptide, may play a crucial role in the pathophysiology of this condition. This study investigated the effect of erythropoietin (EPO) therapy on serum levels of prohepcidin, the prohormone of hepcidin, in patients with end-stage renal disease (ESRD) undergoing chronic dialysis treatment.